We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Cautions on Use of ‘Bayesian’ Statistics in Complex Trials
FDA Cautions on Use of ‘Bayesian’ Statistics in Complex Trials
The FDA urges trial sponsors who may be thinking of using Bayesian statistics in complex innovative trials to consider alternatives, in a new draft guidance issued Monday.